tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

GNTA Stock Latest News

Genenta Science Announces ADS Sales Agreement
Company AnnouncementsGenenta Science Announces ADS Sales Agreement
2d ago
6K
GNTA
Genenta Science Announces Board Restructuring
PremiumCompany Announcements
Genenta Science Announces Board Restructuring
20d ago
6K
GNTA
Genenta Science Announces Shareholder Meeting
PremiumCompany Announcements
Genenta Science Announces Shareholder Meeting
26d ago
6K
GNTA
Genenta Science’s Loyalty Shares: A Double-Edged Sword for ADS Liquidity and Investor Influence?
PremiumCompany Announcements
Genenta Science’s Loyalty Shares: A Double-Edged Sword for ADS Liquidity and Investor Influence?
28d ago
GNTA
Genenta Science doses first three TEM-GBM patients in Cohort 8
PremiumThe Fly
Genenta Science doses first three TEM-GBM patients in Cohort 8
3M ago
GNTA
Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors
PremiumPress ReleasesGenenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors
3M ago
GNTA
Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments
PremiumPress Releases
Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments
9M ago
GNTA
Genenta Science SpA(ADR) trading resumes
PremiumThe Fly
Genenta Science SpA(ADR) trading resumes
10M ago
GNTA
Genenta Science SpA(ADR) trading halted, volatility trading pause
PremiumThe Fly
Genenta Science SpA(ADR) trading halted, volatility trading pause
10M ago
GNTA
Genenta Science assumed with a Buy at Roth MKM
PremiumThe Fly
Genenta Science assumed with a Buy at Roth MKM
10M ago
GNTA
Genenta Science receives Orphan Drug Designation from EC for Temferon
PremiumThe Fly
Genenta Science receives Orphan Drug Designation from EC for Temferon
10M ago
GNTA
The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of Glioma
PremiumPress Releases
The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of Glioma
10M ago
GNTA
Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F Filing
PremiumPress ReleasesGenenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F Filing
1y ago
GNTA
Genenta Science sees cash sufficient to continue operations into 1Q25
PremiumThe Fly
Genenta Science sees cash sufficient to continue operations into 1Q25
1y ago
GNTA
Genenta Science reports 2022 net loss EUR 8.5M vs. EUR 5.5M last year
PremiumThe Fly
Genenta Science reports 2022 net loss EUR 8.5M vs. EUR 5.5M last year
1y ago
GNTA
Genenta Announces Extension of License Agreement with Ospedale San Raffaele to All Solid Tumor Indications
PremiumPress Releases
Genenta Announces Extension of License Agreement with Ospedale San Raffaele to All Solid Tumor Indications
1y ago
GNTA
Genenta announces extension of license agreement with OSR
PremiumThe Fly
Genenta announces extension of license agreement with OSR
1y ago
GNTA
FDA Grants Orphan Drug Designation to Temferon for Treatment of Glioblastoma Multiforme
PremiumPress Releases
FDA Grants Orphan Drug Designation to Temferon for Treatment of Glioblastoma Multiforme
1y ago
GNTA
Genenta Science: FDA grants Orphan Drug Designation to Temferon
PremiumThe Fly
Genenta Science: FDA grants Orphan Drug Designation to Temferon
1y ago
GNTA
Genenta Science treatment of glioblastoma multiforme gets FDA orphan status
PremiumThe FlyGenenta Science treatment of glioblastoma multiforme gets FDA orphan status
1y ago
GNTA
Genenta, AGC Biologics enter development, manufacturing service agreement
PremiumThe Fly
Genenta, AGC Biologics enter development, manufacturing service agreement
1y ago
GNTA
Genenta Science and AGC Biologics Enter Development and Manufacturing Service Agreement
PremiumPress Releases
Genenta Science and AGC Biologics Enter Development and Manufacturing Service Agreement
1y ago
GNTA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >